NCT00625196View on ClinicalTrials.gov

Comparing Two Respiratory Drugs in Combination and Separately From a Novel Inhaler Device in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 27, 2008

Primary Completion Date

May 6, 2008

Study Completion Date

May 6, 2008

Conditions
Asthma
Interventions
DRUG

Fluticasone foroate/ vilanterol

Fluticasone foroate/ vilanterol 800 micrograms/ 50 micrograms will be available as dry powder inhaler.

DRUG

Fluticasone foroate

Fluticasone foroate 800 micrograms will be available as dry powder inhaler.

DRUG

Vilanterol

Vilanterol will be available as dry powder inhaler.

DRUG

Placebo

Placebo will be supplied as dry powder inhaler.

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00625196 - Comparing Two Respiratory Drugs in Combination and Separately From a Novel Inhaler Device in Healthy Japanese Subjects | Biotech Hunter | Biotech Hunter